Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Prologis Inc (PLD) Price & Performance

Novartis AGTrade
Prologis IncTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Prologis Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Prologis Inc trades at $151.05 (market cap $137.50B). The key difference: Novartis AG is far larger — about 2.1× Prologis Inc's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.

NVSPLD
Market Cap
$290.25B$137.50B
Sector
HealthReal Estate
52-Week High
$168.62$149.96
52-Week Low
$113.50$104.08
Enterprise Value
$330.27B$172.18B
Dividend Yield
3.17%2.9%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Prologis Inc

Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.

Read more on PLD